Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pre-Treatment of Highly Suspicious Pigmented Skin Lesions With Interleukin-2

NCT03233828 is registered in ClinicalTrials.gov with Carman Giacomantonio as lead sponsor.

NCT NCT03233828
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03233828 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pre-Treatment of Highly Suspicious Pigmented Skin Lesions With Interleukin-2
Lead sponsor
Carman Giacomantonio
Phase
Phase 3
Overall status
Terminated
Start date
October 30, 2019
Completion date
November 27, 2019
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma (skin), melanoma in situ